News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
679,115 Results
Type
Article (38784)
Company Profile (247)
Press Release (640084)
Section
Business (203543)
Career Advice (1977)
Deals (35344)
Drug Delivery (78)
Drug Development (80618)
Employer Resources (167)
FDA (16018)
Job Trends (14779)
News (343737)
Policy (32409)
Tag
Academia (2528)
Africa (711)
Alliances (48976)
Alzheimer's disease (1146)
Approvals (15940)
Arizona (174)
Artificial intelligence (69)
Asia (36804)
Australia (5984)
Bankruptcy (350)
Best Places to Work (11283)
Biosimilars (63)
Biotechnology (176)
C2C Services and Suppliers (78797)
California (1885)
Canada (937)
Cancer (491)
Career advice (1647)
Cell therapy (121)
China (150)
Clinical research (63223)
Collaboration (139)
Colorado (79)
Compensation (81)
Connecticut (75)
COVID-19 (2487)
Cystic fibrosis (73)
Data (312)
Diabetes (81)
Diagnostics (5973)
Drug pricing (63)
Earnings (83653)
Employer resources (142)
Europe (78627)
Events (107821)
Executive appointments (153)
FDA (16245)
Florida (265)
Funding (148)
Gene therapy (92)
GLP-1 (510)
Government (4291)
Healthcare (18613)
Hotbed/Location (480954)
Illinois (255)
Indiana (147)
Infectious disease (2516)
Inflammatory bowel disease (91)
Interviews (305)
IPO (16202)
Job creations (3618)
Job search strategy (1412)
Kansas (94)
Layoffs (393)
Legal (7831)
Lung cancer (110)
Manufacturing (86)
Maryland (397)
Massachusetts (1528)
Medical device (13046)
Medtech (13051)
Mergers & acquisitions (19014)
Metabolic disorders (247)
Michigan (124)
Minnesota (214)
Neuroscience (1291)
New Jersey (579)
New York (595)
NextGen Class of 2024 (6479)
Non-profit (4457)
North Carolina (588)
Northern California (825)
Obesity (146)
Ohio (104)
Opinion (171)
Patents (74)
Pennsylvania (581)
People (55848)
Pharmaceutical (60)
Phase I (19587)
Phase II (27844)
Phase III (20805)
Pipeline (112)
Postmarket research (2546)
Preclinical (8317)
Press Release (64)
Rare diseases (130)
Real estate (5882)
Recruiting (63)
Regulatory (21199)
Research institute (2304)
Resumes & cover letters (346)
South America (1085)
Southern California (766)
Startups (3559)
Texas (240)
United States (8571)
Vaccines (473)
Washington State (253)
Weight loss (127)
Date
Today (121)
Last 7 days (634)
Last 30 days (2444)
Last 365 days (37124)
2024 (26202)
2023 (40074)
2022 (51175)
2021 (55714)
2020 (54089)
2019 (46541)
2018 (35020)
2017 (32113)
2016 (31482)
2015 (37553)
2014 (31319)
2013 (26348)
2012 (28570)
2011 (29263)
2010 (27329)
679,115 Results for "hologic inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Hologic Announces Financial Results for Second Quarter of Fiscal 2024
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal second quarter ended March 30, 2024.
May 2, 2024
·
31 min read
Business
Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
Bayer and Hologic, Inc. (Nasdaq: HOLX) today announced a first-of-its-kind collaboration to deliver a coordinated solution for contrast-enhanced mammography (CEM).
April 11, 2024
·
4 min read
Business
Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the second quarter of fiscal 2024 on Thursday, May 2, after the market closes.
April 2, 2024
·
1 min read
Genetown
Hologic to Unveil Groundbreaking AI Research at ECR 2024
Hologic, Inc. (Nasdaq: HOLX) continues to deliver on its commitment to advancing women’s health by unveiling new research in artificial intelligence (AI) and offering innovative educational opportunities at the annual European Congress of Radiology (ECR) in Vienna, Austria from February 28 to March 2.
February 27, 2024
·
5 min read
Genetown
Hologic to Webcast Presentations at Upcoming Investor Conferences - February 26, 2024
Hologic, Inc. announced that the Company will present at the following upcoming investor conferences: Raymond James’ 45th Annual Institutional Investors Conference on Monday, March 4 at 8:40 a.m. Eastern Time.
February 26, 2024
·
1 min read
Business
Hologic Announces Financial Results for First Quarter of Fiscal 2024
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal first quarter ended December 30, 2023.
February 1, 2024
·
29 min read
Business
Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024
Hologic, Inc. announced preliminary revenue results for its first fiscal quarter ended December 30, 2023.
January 7, 2024
·
12 min read
Business
Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the first quarter of fiscal 2024 on Thursday, February 1, after the market closes.
January 4, 2024
·
1 min read
Genetown
Hologic to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 1:30 p.m. Pacific Time.
January 2, 2024
·
1 min read
Business
Hologic Announces Financial Results for Fourth Quarter of Fiscal 2023
Hologic, Inc. (Nasdaq: HOLX) announced today the Company’s financial results for the fiscal fourth quarter ended September 30, 2023.
November 9, 2023
·
32 min read
1 of 67,912
Next
